Literature DB >> 1519471

Epilepsy and anomalies of neuronal migration: MRI and clinical aspects.

E Brodtkorb1, G Nilsen, O Smevik, P A Rinck.   

Abstract

Neuronal migration disorders are the result of disturbed brain development. In such disorders, neurons are abnormally located. In diagnosing these conditions, magnetic resonance imaging is superior to any other imaging technique. This enables us to improve our knowledge of the clinical correlates of neuronal migration. With reference to migrational disorder, a retrospective study of all 303 patients with epileptic seizures referred for magnetic resonance imaging during a 3-year period was performed, 13 patients (aged 12-41, mean age 27) were identified. They represent 4.3% of the entire study group. Of the patients with known epilepsy, 6.7% and of the mentally retarded, 13.7% had migrational disorders. Four patients had schizencephaly as the dominant finding, one was classified as hemimegalencephaly, 2 had isolated heterotopias, and 6 had localized pachy- and/or poly-microgyria. The clinical pictures are complex. Ectopias of grey matter are recognised foci of epilepsy, but from an epileptological and a clinical viewpoint little attention has been given to these disorders. The present study shows that malmigration is not rare in epilepsy patients, especially not in the mentally retarded.

Entities:  

Mesh:

Year:  1992        PMID: 1519471     DOI: 10.1111/j.1600-0404.1992.tb08049.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  10 in total

1.  Reelin' in Genes for Cortical Dysplasia.

Authors:  Peter B. Crino
Journal:  Epilepsy Curr       Date:  2001-11       Impact factor: 7.500

2.  Can Latent Class Analysis Be Used to Improve the Diagnostic Process in Pediatric Patients with Chronic Ataxia?

Authors:  Samantha Klassen; Brenden Dufault; Michael S Salman
Journal:  Cerebellum       Date:  2017-04       Impact factor: 3.847

Review 3.  Similarities and differences between the Wnt and reelin pathways in the forming brain.

Authors:  Orly Reiner; Tamar Sapir
Journal:  Mol Neurobiol       Date:  2005       Impact factor: 5.590

4.  An unusual clinical presentation of bilateral schizencephaly.

Authors:  M Avellanet; R M Mirapeix; D Escudero; C Riera; J M Domenech-Mateu
Journal:  Surg Radiol Anat       Date:  1996       Impact factor: 1.246

5.  Hemimegalencephaly. Histological, immunohistochemical, ultrastructural and cytofluorimetric study of six patients.

Authors:  C Bosman; R Boldrini; L Dimitri; C Di Rocco; A Corsi
Journal:  Childs Nerv Syst       Date:  1996-12       Impact factor: 1.475

Review 6.  Surgical pathology of epilepsy-associated non-neoplastic cerebral lesions: a brief introduction with special reference to hippocampal sclerosis and focal cortical dysplasia.

Authors:  Hajime Miyata; Tomokatsu Hori; Harry V Vinters
Journal:  Neuropathology       Date:  2013-03-27       Impact factor: 1.906

7.  ALLN rescues an in vitro excitatory synaptic transmission deficit in Lis1 mutant mice.

Authors:  Joy Y Sebe; Marina Bershteyn; Shinji Hirotsune; Anthony Wynshaw-Boris; Scott C Baraban
Journal:  J Neurophysiol       Date:  2012-10-24       Impact factor: 2.714

8.  Structural abnormalities in patients with insular/peri-insular epilepsy: spectrum, frequency, and pharmacoresistance.

Authors:  M-C Chevrier; C Bard; F Guilbert; D K Nguyen
Journal:  AJNR Am J Neuroradiol       Date:  2013-06-27       Impact factor: 3.825

9.  Polymicrogyria-associated epilepsy: a multicenter phenotypic study from the Epilepsy Phenome/Genome Project.

Authors:  Catherine Shain; Sriram Ramgopal; Zianka Fallil; Isha Parulkar; Richard Alongi; Robert Knowlton; Annapurna Poduri
Journal:  Epilepsia       Date:  2013-06-10       Impact factor: 5.864

10.  Surgery for drug resistant partial epilepsy in children with focal cortical dysplasia: anatomical-clinical correlations and neurophysiological data in 10 patients.

Authors:  S Francione; P Vigliano; L Tassi; F Cardinale; R Mai; G Lo Russo; C Munari
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-11       Impact factor: 10.154

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.